Authors:
DURHAM LK
LONGINI IM
HALLORAN ME
CLEMENS JD
NIZAM A
RAO M
Citation: Lk. Durham et al., ESTIMATION OF VACCINE EFFICACY IN THE PRESENCE OF WANING - APPLICATION TO CHOLERA VACCINES, American journal of epidemiology, 147(10), 1998, pp. 948-959
Citation: Me. Halloran, STATISTICAL ISSUES IN PHASE-III HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE TRIAL DESIGN, Journal of the Royal Statistical Society. Series A. Statistics in society, 161, 1998, pp. 265-272
Citation: Gt. Golm et al., SEMIPARAMETRIC MODELS FOR MISMEASURED EXPOSURE INFORMATION IN VACCINETRIALS, Statistics in medicine, 17(20), 1998, pp. 2335-2352
Citation: S. Datta et al., AUGMENTED HIV VACCINE TRIAL DESIGN FOR ESTIMATING REDUCTION IN INFECTIOUSNESS AND PROTECTIVE EFFICACY, Statistics in medicine, 17(2), 1998, pp. 185-200
Authors:
LONGINI IM
SAGATELIAN K
RIDA WN
HALLORAN ME
Citation: Im. Longini et al., OPTIMAL VACCINE TRIAL DESIGN WHEN ESTIMATING VACCINE EFFICACY FOR SUSCEPTIBILITY AND INFECTIOUSNESS FROM MULTIPLE POPULATIONS, Statistics in medicine, 17(10), 1998, pp. 1121-1136
Citation: Ds. Stephens et al., SYMPOSIUM ON POPULATION BIOLOGY, EVOLUTION, AND CONTROL OF INFECTIOUS-DISEASES - INTRODUCTION, The American journal of the medical sciences, 315(2), 1998, pp. 63-63
Authors:
HALLORAN ME
ANDERSON RM
AZEVEDONETO RS
BELLINI WJ
BRANCH O
BURKE MA
COMPANS R
DAY K
GOODING L
GUPTA S
KATZ J
KEW O
KEYSERLING H
KRAUSE R
LAL AA
MASSAD E
MCLEAN AR
ROSA P
ROTA P
WIENER P
WYNN SG
ZANETTA DMT
Citation: Me. Halloran et al., POPULATION BIOLOGY, EVOLUTION, AND IMMUNOLOGY OF VACCINATION AND VACCINATION PROGRAMS, The American journal of the medical sciences, 315(2), 1998, pp. 76-86
Authors:
BERTOLLI J
PANGI C
FRERICHS R
HALLORAN ME
Citation: J. Bertolli et al., A CASE-CONTROL STUDY OF THE EFFECTIVENESS OF THE BCG VACCINE FOR PREVENTING LEPROSY IN YANGON, MYANMAR, International journal of epidemiology, 26(4), 1997, pp. 888-896
Citation: Me. Halloran et al., STUDY DESIGNS FOR EVALUATING DIFFERENT EFFICACY AND EFFECTIVENESS ASPECTS OF VACCINES, American journal of epidemiology, 146(10), 1997, pp. 789-803
Citation: Im. Longini et al., MEASURING VACCINE EFFICACY FOR BOTH SUSCEPTIBILITY TO INFECTION AND REDUCTION IN INFECTIOUSNESS FOR PROPHYLACTIC HIV-1 VACCINES, Journal of acquired immune deficiency syndromes and human retrovirology, 13(5), 1996, pp. 440-447
Citation: Ph. Rhodes et al., COUNTING PROCESS MODELS FOR INFECTIOUS-DISEASE DATA - DISTINGUISHING EXPOSURE TO INFECTION FROM SUSCEPTIBILITY, Journal of the Royal Statistical Society. Series B: Methodological, 58(4), 1996, pp. 751-762
Citation: Oj. Devine et al., IDENTIFYING AREAS WITH ELEVATED DISEASE INCIDENCE RATES USING EMPIRICAL BAYES ESTIMATORS, Geographical analysis, 28(3), 1996, pp. 187-199
Authors:
MOSURE DJ
BERMAN S
KLEINBAUM D
HALLORAN ME
Citation: Dj. Mosure et al., PREDICTORS OF CHLAMYDIA-TRACHOMATIS INFECTION AMONG FEMALE ADOLESCENTS - A LONGITUDINAL ANALYSIS, American journal of epidemiology, 144(10), 1996, pp. 997-1003
Citation: Me. Halloran et al., ESTIMABILITY AND INTERPRETATION OF VACCINE EFFICACY USING FRAILTY MIXING MODELS, American journal of epidemiology, 144(1), 1996, pp. 83-97
Authors:
HABER MJ
HALLORAN ME
LONGINI IM
ORENSTEIN WA
Citation: Mj. Haber et al., THE EFFECT OF DISEASE PRIOR TO AN OUTBREAK ON ESTIMATES OF VACCINE EFFICACY FOLLOWING THE OUTBREAK - REPLY, American journal of epidemiology, 143(9), 1996, pp. 961-961
Citation: M. Haber et al., ON INDIVIDUAL AND POPULATION EFFECTIVENESS OF VACCINATION, International journal of epidemiology, 24(6), 1995, pp. 1249-1260
Citation: Cp. Noronha et al., ASSESSMENT OF THE DIRECT EFFECTIVENESS OF BC MENINGOCOCCAL VACCINE INRIO-DE-JANEIRO, BRAZIL - A CASE-CONTROL STUDY, International journal of epidemiology, 24(5), 1995, pp. 1050-1057